SCHEDULE 13G/A: Davis Selected Advisers Discloses 6.0% Stake in Viatris Inc.
Beneficial Ownership Report
Investment adviser Davis Selected Advisers has reported a 6.0% beneficial ownership stake in pharmaceutical company Viatris Inc., holding over 64 million shares.
Summary
- Davis Selected Advisers, an investment adviser based in Colorado, has filed an Amendment No. 3 to Schedule 13G regarding its beneficial ownership in Viatris Inc.
- As of March 31, 2025, Davis Selected Advisers beneficially owns an aggregate of 64,948,236 shares of Viatris Inc. Common Stock.
- This ownership represents 6.0% of the class of securities.
- Davis Selected Advisers holds sole voting power over 62,570,471 shares and sole dispositive power over all 64,948,236 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of Viatris Inc.
Sentiment
Score: 6
Explanation: The disclosure of a significant institutional ownership stake by Davis Selected Advisers in Viatris Inc. is generally viewed as a positive signal of investor confidence, although the filing itself is purely factual and does not contain performance data.
Positives
- The disclosure of a significant institutional ownership stake by Davis Selected Advisers may signal confidence from a reputable investment adviser in Viatris Inc.'s long-term prospects.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of institutional ownership and does not provide specific insights into broader industry trends or competitive positioning beyond the fact that a significant investment adviser holds a stake in a major pharmaceutical company.
Stakeholder Impact
- Shareholders: The disclosure of a significant institutional stake by Davis Selected Advisers could influence investor perception and potentially the stock price, as it indicates a notable institutional investor's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement (reporting period end date) |
| 05/08/2025 | Date of filing of this statement |
Keywords
Viatris Inc., Davis Selected Advisers, Beneficial Ownership, SEC Filing, Schedule 13G, Common Stock, Institutional Investor, Pharmaceuticals, Investment Adviser
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.